GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles prevention. This new syringe presentation is ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix for the prevention of shingles.

Between being a radio show host, a lead singer in a touring band, and an avid horseback rider, TV personality Faith Martin is living her best life. There's little downtime in Martin's active day ...

GSK plc announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

During this conference where the launch of the "Shingrix" vaccine was announced, Engineer Hassan Fahmi General Manager of GSK Egypt, spoke about the importance of introducing the "Shingrix ...

GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for its vaccine for shingles, Shingrix ...

GSK reported Q4 sales of $10.40B ... each impacting full year growth by 1 percentage point. Shingrix sales reached 848 million pounds, down 7% (-4% at constant currency). Also Read: Moderna ...

GSK plc GSK reported fourth-quarter 2024 core ... Sales of the company’s shingles vaccine, Shingrix, fell 4% during the quarter due to lower demand in the U.S. and International markets.

Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE ...

GSK’s fourth-quarter Vaccine sales declined 12% due to lower sales of its RSV vaccine Arexvy and shingles vaccine, Shingrix. Arexvy generated £158 million during the quarter, down 69% year ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK (LON:GSK)'s vaccine for ...